What is the usual therapeutic dose of Cymbalta (duloxetine) for adults with depression, anxiety, or neuropathic pain, and how should it be adjusted for older adults or those with hepatic impairment?

Therapeutic Dose of Cymbalta (Duloxetine)

Standard Dosing for Adults

For major depressive disorder and generalized anxiety disorder, start duloxetine at 60 mg once daily; for neuropathic pain conditions (diabetic peripheral neuropathy, fibromyalgia, chronic musculoskeletal pain), begin at 30 mg once daily for one week, then increase to the target dose of 60 mg once daily. 1

Depression (Major Depressive Disorder)

• Starting dose: 40 mg/day (given as 20 mg twice daily) to 60 mg/day (once daily or 30 mg twice daily) 1
• Alternative initiation: Some patients benefit from starting at 30 mg once daily for 1 week to adjust before increasing to 60 mg once daily 1
• Maximum studied dose: 120 mg/day, though there is no evidence that doses greater than 60 mg/day confer additional benefits 1
• Optimal therapeutic dose: 60 mg once daily provides the best balance of efficacy and tolerability 2

Generalized Anxiety Disorder

• Adults <65 years: Initiate at 60 mg once daily 1
  • May start at 30 mg once daily for 1 week if tolerability is a concern, then increase to 60 mg 1
  • While 120 mg once daily showed efficacy, no evidence supports benefit beyond 60 mg/day 1
  • If increasing beyond 60 mg, use 30 mg increments 1
• Pediatric patients (7-17 years): Start at 30 mg once daily for 2 weeks before considering increase to 60 mg once daily 1
  • Recommended range: 30-60 mg once daily 1
  • Maximum studied: 120 mg/day 1

Diabetic Peripheral Neuropathic Pain

• Standard dose: 60 mg once daily 1
• No benefit from higher doses: Doses above 60 mg/day do not provide additional significant benefit and are clearly less well tolerated 1
• For tolerability concerns: Consider lower starting dose 1
• Evidence base: Duloxetine 60 mg daily achieves 50% pain reduction in diabetic neuropathy with a number needed to treat (NNT) of 5 3

Fibromyalgia

• Starting dose: 30 mg once daily for 1 week 1
• Target dose: 60 mg once daily 1
• Some patients respond to 30 mg: The starting dosage may be sufficient for certain individuals 1
• No benefit from higher doses: Dosages greater than 60 mg/day show no additional benefit, even in non-responders, and are associated with higher adverse reaction rates 1
• Evidence base: At 60 mg daily, duloxetine achieves 50% pain reduction with NNT of 8 at 12 weeks 3

Chronic Musculoskeletal Pain

• Starting dose: 30 mg once daily for one week 1
• Target dose: 60 mg once daily 1
• No benefit from higher doses: Even in non-responders to 60 mg, higher dosages do not confer additional benefit and increase adverse reactions 1

Dosing for Older Adults

In geriatric patients with generalized anxiety disorder, initiate duloxetine at 30 mg once daily for 2 weeks before considering an increase to the target dose of 60 mg/day. 1

• After the initial 2-week period at 30 mg, patients may benefit from doses above 60 mg once daily 1
• If increasing beyond 60 mg, use 30 mg increments 1
• Maximum studied dose: 120 mg/day 1

Dosing Adjustments for Hepatic Impairment

Avoid duloxetine in patients with chronic liver disease or cirrhosis. 1

• Duloxetine is contraindicated in hepatic impairment due to risk of hepatotoxicity 1
• The drug is extensively metabolized by hepatic cytochrome P450 enzymes (CYP1A2 and CYP2D6), making hepatic dysfunction a significant safety concern 4

Dosing Adjustments for Renal Impairment

Avoid duloxetine in patients with severe renal impairment (GFR <30 mL/minute). 1

• For diabetic neuropathy patients (who frequently have renal complications), consider a lower starting dosage and gradual increase 1
• Since diabetes is often complicated by renal disease, exercise particular caution in this population 1

Administration Guidelines

• Swallow capsules whole: Do not chew, crush, open, or sprinkle contents on food, as this affects the enteric coating 1
• With or without food: Duloxetine may be administered regardless of meals 1
• Time of day: No specific time requirement 1
• Missed dose: Take as soon as remembered unless it is almost time for the next dose; never take two doses simultaneously 1

Discontinuation Protocol

Taper duloxetine gradually rather than stopping abruptly to minimize discontinuation symptoms. 1

• Common discontinuation symptoms: Dizziness, headache, nausea, diarrhea, paresthesia, irritability, vomiting, insomnia, anxiety, hyperhidrosis, and fatigue 1
• Discontinuation-emergent adverse events (most commonly nausea and dizziness) occur in up to one-third of patients 4

Evidence Quality and Clinical Efficacy

Depression

• Duloxetine 60 mg once daily shows significant improvements versus placebo in core emotional symptoms and painful physical symptoms associated with depression 2
• Improvements become apparent after 1-2 weeks of treatment at 60 mg once daily 2
• Short-term efficacy (≤15 weeks) is noninferior to paroxetine 20 mg once daily and has similar global benefit-risk profile to venlafaxine XR 150-225 mg/day 2

Generalized Anxiety Disorder

• Duloxetine 60-120 mg once daily for 9-10 weeks significantly improves Hamilton Anxiety Rating Scale (HAM-A) scores compared to placebo 4
• Improvements in anxiety, functional impairment, health-related quality of life, and patient well-being are consistently demonstrated 4
• Longer-term treatment (26 weeks) significantly delays time to relapse compared to placebo 4

Neuropathic Pain

• Diabetic peripheral neuropathy: Duloxetine 60 mg daily achieves ≥50% pain reduction with risk ratio 1.73 (NNT = 5) at 12 weeks 3
• Fibromyalgia: Duloxetine 60 mg daily achieves ≥50% pain reduction with risk ratio 1.57 (NNT = 8) at 12 weeks 3
• The 20 mg daily dose is NOT effective for neuropathic pain 5

Common Adverse Effects

• Most frequent: Nausea, dry mouth, headache, constipation, dizziness, fatigue 4
• Dose-dependent: Adverse events increase with higher doses (60 mg > 120 mg > 20 mg) 4, 3
• Discontinuation rate: Approximately 16% of participants stop duloxetine due to adverse effects 3, 5
• Serious adverse events: Rare 4, 3
• Blood pressure: Duloxetine increases blood pressure in a dose-dependent manner 6

Important Drug Interactions

Avoid concomitant use of duloxetine with potent CYP1A2 inhibitors, and use caution when combining with drugs extensively metabolized by CYP2D6, particularly those with narrow therapeutic index. 4

• Duloxetine is metabolized by CYP1A2 and CYP2D6 4
• Duloxetine is a moderate inhibitor of CYP2D6 4
• MAOI interactions: Allow at least 14 days between discontinuing an MAOI and starting duloxetine; allow at least 5 days after stopping duloxetine before starting an MAOI 1

Common Pitfalls to Avoid

• Do not initiate at 60 mg in all patients: Starting at 30 mg for one week improves tolerability in fibromyalgia, chronic musculoskeletal pain, and anxiety-prone patients 1
• Do not exceed 60 mg/day without clear rationale: Higher doses (120 mg) do not provide additional benefit in most conditions and increase adverse effects 1, 3
• Do not use in hepatic or severe renal impairment: These are contraindications due to safety concerns 1
• Do not stop abruptly: Gradual taper is essential to minimize discontinuation syndrome 1
• Do not assume 20 mg is therapeutic for pain: This dose is ineffective for neuropathic pain conditions 5